S100A13 Is Involved in the Regulation of Fibroblast Growth Factor-1 and p40 Synaptotagmin-1 Release in Vitro
Open Access
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (35) , 22224-22231
- https://doi.org/10.1074/jbc.273.35.22224
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Two Distinct Anti-allergic Drugs, Amlexanox and Cromolyn, Bind to the Same Kinds of Calcium Binding Proteins, except Calmodulin, in Bovine Lung ExtractBiochemical and Biophysical Research Communications, 1997
- Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cellsOncogene, 1997
- Characterization of the Human and Mouse cDNAsCoding for S100A13, a New Member of the S100 Protein FamilyBiochemical and Biophysical Research Communications, 1996
- The Cysteine Residue Responsible for the Release of Fibroblast Growth Factor-1 Resides in a Domain Independent of the Domain for Phosphatidylserine BindingPublished by Elsevier ,1995
- Annexin II tetramer: structure and functionMolecular and Cellular Biochemistry, 1995
- Synaptotagmin I is a high affinity receptor for clathrin AP-2: Implications for membrane recyclingCell, 1994
- Binding Site of Annexin XI on the Calcyclin MoleculeBiochemical and Biophysical Research Communications, 1993
- Structural analysis of the gene for human acidic fibroblast growth factorBiochemical and Biophysical Research Communications, 1989
- Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐lifeJournal of Cellular Physiology, 1989
- The Antiallergic Agent Amoxanox Suppresses SRS-A Generation by Inhibiting LipoxygenaseInternational Archives of Allergy and Immunology, 1986